Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study) (Q36721696)
Jump to navigation
Jump to search
scientific article published on 13 December 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study) |
scientific article published on 13 December 2012 |
Statements
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study) (English)
Elizabeth Buchbinder
Howard A Liebman
Kenneth A Bauer
Thomas Caughey
Federico Campigotto
Rachel Rosovsky
Simon Mantha
Craig M Kessler
Jonathan Eneman
Vidya Raghavan
Heinz-Joseph Lenz
Andrea Bullock
13 December 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference